Innovex is transitioning from a cyclical equipment supplier to a capital-light consolidator leveraging global distribution for niche well technologies. Recent acquisitions, notably TCO Group and DIS, validate the cross-selling model, driving accretive EPS and high-margin consumable growth within INVX's expanding international footprint. Q2 2026 saw 9% revenue growth, a 2.2-point gross margin improvement, and robust free cash flow, with management guiding for further margin expansion and EBITDA growth in Q3.
Innovex International (INVX) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.3 per share. This compares to earnings of $0.28 per share a year ago.
Here is how Innovex International (INVX) and Siemens Energy AG Unsponsored ADR (SMERY) have performed compared to their sector so far this year.
Innovex International, Inc. (INVX) Q1 2026 Earnings Call Transcript
Innovex International (INVX) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.29 per share a year ago.
Innovex International (INVX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Innovex International, Inc. (INVX) Q4 2025 Earnings Call Transcript
Innovex International (INVX) came out with quarterly earnings of $0.2 per share, missing the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.47 per share a year ago.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Does Innovex International (INVX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Does Innovex International (INVX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Innovex International has surged 31% YTD, outperforming the S&P 500 and XLE, yet remains reasonably valued with strong growth prospects. INVX's acquisition of Citadel enhances its product portfolio and is expected to be 8% accretive to EPS, supporting international expansion and resilience to oil price declines. A pristine balance sheet with net cash and no net debt strengthens INVX's ability to weather industry cycles and pursue further growth through acquisitions.